Kí ni “Clear” túmọ̀ sí?
Eranko ko gbe iyipada. Kii yoo ni idagbasoke arun na ati pe kii yoo kọja lori rẹ.
Cerebellar Abiotrophy (CA) is a genetic disorder affecting horses, leading to progressive loss of coordination and balance. A DNA test for CA helps identify carriers and affected horses, enabling breeders to make informed decisions and reduce the risk of passing this debilitating condition to offspring. Early detection through genetic testing is crucial for managing breeding programs and maintaining healthy equine populations. This test is especially important for breeds prone to CA, such as Arabian horses. By using the CA DNA test, owners can ensure better care and improve the overall welfare of their horses. Stay proactive and protect your equine investment with reliable genetic screening for Cerebellar Abiotrophy.
Cerebellar Abiotrophy (CA) is a genetic disorder in horses that affects the cerebellum, leading to coordination and balance issues. A DNA test can identify carriers and affected horses by detecting the specific mutation responsible for CA. This test helps breeders make informed decisions to avoid producing affected foals. Early diagnosis through DNA testing improves management and care for affected horses. Overall, the CA DNA test is a valuable tool for promoting healthier breeding practices.
Idanwo DNA yii wa pẹlu ti o bẹrẹ lati idii wa Basic - ati ki o jẹ tun apa ti awọn akopọ Basic, Standard, Advanced, Complete.
Wo Awọn akopọ Idanwo DNA →Cerebellar Abiotrophy (CA) is a neurological condition observed in horses, characterized by the degeneration of the cerebellum, a part of the brain responsible for coordination and balance. This condition typically manifests in young horses, often between the ages of 6 months and 3 years, leading to significant motor dysfunction. Affected horses may exhibit symptoms such as incoordination, difficulty standing, and abnormal gait, which can severely impact their quality of life and training potential.
CA is recognized as a hereditary disorder, often associated with specific genetic mutations. The condition arises due to the improper development and subsequent degeneration of Purkinje cells within the cerebellum. These cells play a crucial role in motor control, and their loss leads to the clinical signs observed in affected individuals. Understanding the genetic underpinnings of CA has paved the way for DNA testing, which can identify carriers and help breeders make informed decisions.
The clinical signs of CA can vary in severity but generally include a range of neurological deficits. Common symptoms include a lack of coordination, especially in the hind limbs, a wide-based stance, and difficulty with balance. Affected horses may also show signs of intention tremors, where they exhibit tremors when trying to perform tasks such as eating or drinking. These symptoms can significantly hinder the horse's ability to engage in routine activities and can lead to frustration for both the animal and its handler.
Diagnosing CA typically involves a combination of clinical evaluation and genetic testing. Veterinarians assess the horse's neurological function and may perform additional tests to rule out other conditions that could cause similar symptoms. Genetic testing plays a crucial role in confirming the diagnosis and understanding the horse's genetic predisposition to the condition.
Currently, there is no cure for Cerebellar Abiotrophy, and management focuses on supportive care and ensuring the horse's safety. Affected horses may require specialized handling and training approaches to accommodate their coordination issues. The prognosis for horses with CA varies; some may lead relatively normal lives with adaptations, while others may need to be retired from work due to the severity of their symptoms.
Cerebellar Abiotrophy is a significant concern in equine health, particularly due to its genetic nature and impact on horse performance and welfare. DNA testing serves as a valuable tool for breeders and owners, providing insights into the likelihood of developing this condition. Increased awareness and understanding of CA are essential for effective management and the continued health of affected horses.
Eranko ko gbe iyipada. Kii yoo ni idagbasoke arun na ati pe kii yoo kọja lori rẹ.
Rara. Eranko naa ni ilera ni gbogbogbo ṣugbọn o le tan iyipada si rẹ ọmọ.
O gbe awọn ẹda ti o yipada meji. Awọn ami ile-iwosan ni a nireti da lori arun na. Ko yẹ ki o jẹ ajọbi.
Diẹ ninu awọn arun ti wa ni ibalopo-ti sopọ mọ, ki wọn ikosile yatọ da lori awọn ibalopo eranko.
This DNA test detects the mutation associated with Cerebellar Abiotrophy (CA) in order to identify clear, carrier, or at-risk animals.
Idanwo DNA ṣe iranlọwọ fun awọn ajọbi gbero awọn ibarasun ailewu ati dinku eewu ti gbigbe iyipada si awọn ọmọ.
Ipo ogún ti a royin fun idanwo yii jẹ Recessive Autosomal.
This test analyses the mutation MUTYH c.541-13539C/T.
Ko dandan. Itumọ da lori ilana ogún ati genotype abajade.
Brault Leah S, Cooper Caitlin A, Famula Thomas R, Murray James D, Penedo M Cecilia T. Mapping of equine cerebellar abiotrophy to ECA2 and identification of a potential causative mutation affecting expression of MUTYH. Genomics. 2011 Feb;97(2):121-9. doi: 10.1016/j.ygeno.2010.11.006. Epub 2010 Nov 30.
Aṣiri rẹ, yiyan rẹ
A lo awọn kuki pataki lati ṣiṣẹ oju opo wẹẹbu naa. Awọn kuki iyan (gẹgẹbi awọn olupese akoonu ti a fi sii) jẹ alaabo nipasẹ aiyipada ati pe o ṣiṣẹ nikan ti o ba gba. O le yi yiyan rẹ pada nigbakugba nipa lilo bọtini “Awọn kuki”.
Ti beere fun mojuto awọn ẹya ara ẹrọ ati aabo. Nigbagbogbo ṣiṣẹ.
Ṣe ilọsiwaju awọn ẹya bii fifipamọ ayanfẹ tabi awọn ifibọ ti kii ṣe ipolowo.
Ṣe iranlọwọ fun wa ni oye lilo aaye. Alaabo nipasẹ aiyipada.
Ipolowo/titele kọja awọn aaye (diẹ ninu awọn ifibọ fidio/awọn maapu). Alaabo nipasẹ aiyipada.